RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Chronic Hepatitis C
Accession: DOID:9004017
browse the term
Definition: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
Synonyms: primary_id: MESH:D019698
xref: EFO:0004220
GViewer not supported for the selected species.
G
Abca1
ATP binding cassette subfamily A member 1
severity
ISO
DNA:SNP:introns:(rs3890182, rs1883025) (human)
RGD
PMID:28164591
RGD:21066337
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
G
Abcb1
ATP binding cassette subfamily B member 1
treatment susceptibility
ISO
DNA:SNP: :3435C>T(human) DNA:SNP::2677G>T/A(rs2032582)(human)
RGD
PMID:26922556 PMID:29155127
RGD:11574565 RGD:14700907
NCBI chrNW_004955432:4,911,774...5,085,349
G
Abcb11
ATP binding cassette subfamily B member 11
disease_progression treatment susceptibility
ISO
DNA:SNP:cds:c.1331T>C (rs2287622)(human) DNA:SNP:cds:1331T>C, p.V444A,(rs2287622)(human)
RGD
PMID:22681771 PMID:29091211 PMID:29755014
RGD:14402415 RGD:14402416 RGD:14402417
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
G
Adar
adenosine deaminase RNA specific
treatment disease_progression no_association
ISO
DNA:silent mutation:CDS:p.V849V (rs1127309) (human) associated with human immunodeficiency virus infectious disease;DNA:missense mutation:exon 2, 3' utr:p.K384R (rs2229857, rs1127326) (human) DNA:snps, haplotype: (rs7515339, rs903323) (human) DNA:SNP:exon: (rs1127309) (human)
RGD
PMID:17979507 PMID:19434718 PMID:26911666 PMID:29906476
RGD:11554370 RGD:125097513 RGD:125097514 RGD:38599150
NCBI chrNW_004955545:1,078,319...1,106,938
Ensembl chrNW_004955545:1,078,319...1,106,938
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:26293833
RGD:14401718
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Apoe
apolipoprotein E
severity
ISO
DNA:polymorphism:exon:
RGD
PMID:12143056
RGD:7495764
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
Aurka
aurora kinase A
ISO
mRNA:increased expression:CD19+Bcell:
RGD
PMID:20189883
RGD:32716380
NCBI chrNW_004955445:2,831,073...2,853,151
Ensembl chrNW_004955445:2,831,157...2,853,357
G
Ccl5
C-C motif chemokine ligand 5
disease_progression severity treatment
ISO
DNA:SNP: :rs3817656(human) DNA:polymorphism:promoter:-403G>A(human) mRNA:increased expression:liver: DNA:SNPs,haplotype: :
RGD
PMID:12557141 PMID:15368437 PMID:15770052 PMID:29703961
RGD:14995332 RGD:14995334 RGD:14995336 RGD:14995340
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
Ccnd1
cyclin D1
ISO
mRNA:increased expression:CD19+Bcell:
RGD
PMID:20189883
RGD:32716380
NCBI chrNW_004955422:16,449,921...16,462,676
Ensembl chrNW_004955422:16,448,770...16,463,300
G
Ccnd2
cyclin D2
ISO
mRNA:increased expression:CD19+Bcell:
RGD
PMID:20189883
RGD:32716380
NCBI chrNW_004955413:2,083,351...2,108,450
Ensembl chrNW_004955413:2,083,351...2,103,430
G
Cd226
CD226 molecule
treatment
ISO
RGD
PMID:21695691
RGD:40818295
NCBI chrNW_004955402:53,408,861...53,560,896
Ensembl chrNW_004955402:53,473,131...53,560,924
G
Cd274
CD274 molecule
ISO
protein:increased expression:peripheral blood mononuclear cell
RGD
PMID:18086898
RGD:41410796
NCBI chrNW_004955434:9,487,309...9,508,366
Ensembl chrNW_004955434:9,487,315...9,505,904
G
Cldn1
claudin 1
susceptibility
ISO
mRNA:decreased expression:liver (human) associated with intravenous substance abuse;DNA:SNP:promoter, intron:multiple mutations
RGD
PMID:19674288 PMID:21412800
RGD:25330352 RGD:26884350
NCBI chrNW_004955420:17,798,974...17,815,049
Ensembl chrNW_004955420:17,798,974...17,815,205
G
Cpt1a
carnitine palmitoyltransferase 1A
ISO
mRNA, protein:decreased expression:liver hepatocytes
RGD
PMID:15685545
RGD:5683635
NCBI chrNW_004955422:17,105,887...17,159,696
Ensembl chrNW_004955422:17,109,256...17,159,838
G
Ctla4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
DNA:SNP,haplotype:exon,promoter:49A>G,-318 T>C(human)
RGD
PMID:12696006
RGD:14398739
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:serum
RGD
PMID:31127759
RGD:27095949
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
G
Cxcl8
C-X-C motif chemokine ligand 8
treatment
ISO
RGD
PMID:21554996
RGD:150521553
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
G
Foxp3
forkhead box P3
ISO
RGD
PMID:18673437
RGD:38548921
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
G
Ggt1
gamma-glutamyltransferase 1
severity
ISO
RGD
PMID:10934805
RGD:14747019
NCBI chrNW_004955455:8,082,578...8,099,523
G
Gpt
glutamic--pyruvic transaminase
ISO
protein:increased activity:plasma
RGD
PMID:22922605
RGD:14975251
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
G
Gpt2
glutamic--pyruvic transaminase 2
ISO
protein:increased activity:plasma
RGD
PMID:22922605
RGD:14975251
NCBI chrNW_004955474:8,248,622...8,285,449
Ensembl chrNW_004955474:8,250,759...8,285,227
G
Ido1
indoleamine 2,3-dioxygenase 1
ISO
mRNA, protein:increased expression, increased activity:monocytes,myeloid dendritic cells,serum (human)
RGD
PMID:25605587
RGD:39939081
NCBI chrNW_004955536:2,944,770...2,955,829
Ensembl chrNW_004955536:2,943,611...2,955,829
G
Igf2
insulin like growth factor 2
severity
ISO
DNA:SNPs, haplotype:multiple
RGD
PMID:16750516
RGD:14401723
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
G
Il10
interleukin 10
susceptibility treatment no_association
ISO
DNA:polymorphism:promoter: DNA:SNP:promoter:-592C>A (rs1800872) (human) protein:increased expression:serum: DNA:SNP:promoter: rs3021094, rs3024498 (human)
RGD
PMID:25708446 PMID:26095186 PMID:29247709
RGD:14700655 RGD:14975141 RGD:38456002
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Il12b
interleukin 12B
severity
ISO
DNA:SNP:3' utr:+1188A>C (human)
RGD
PMID:15871664
RGD:14401721
NCBI chrNW_004955408:13,302,506...13,316,300
Ensembl chrNW_004955408:13,304,219...13,312,620
G
Il17d
interleukin 17D
severity
ISO
associated with human immunodeficiency virus infectious disease;mRNA:increased expression:blood plasma (human)
RGD
PMID:27875997
RGD:40903073
NCBI chrNW_004955497:1,499,700...1,506,557
G
Il18
interleukin 18
disease_progression treatment
ISO
DNA:SNP:promoter:-607C>A (rs1946518)(human)
RGD
PMID:19740312 PMID:25198668
RGD:14696651 RGD:14696656
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il2
interleukin 2
treatment
ISO
RGD
PMID:12673448
RGD:14807336
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
G
Il21
interleukin 21
ameliorates
ISO
protein:increased expression:liver, blood, CD4-positive, alpha-beta T cell (human)
RGD
PMID:24170093
RGD:127285373
NCBI chrNW_004955428:18,057,096...18,065,492
Ensembl chrNW_004955428:18,057,096...18,065,492
G
Il27
interleukin 27
ameliorates
ISO
DNA:SNP:promoter:-964A>G (rs153109) (human)
RGD
PMID:27221901
RGD:126790538
NCBI chrNW_004955493:6,712,005...6,717,417
Ensembl chrNW_004955493:6,712,005...6,717,417
G
Il4
interleukin 4
treatment
ISO
DNA:SNPs:promoter:-590C>T,-33T>C (human) associated with factor VIII deficiency;protein:increased expression:serum:
RGD
PMID:22594992 PMID:23591975 PMID:25708446
RGD:14696678 RGD:14696686 RGD:38456002
NCBI chrNW_004955408:4,058,052...4,065,999
G
Il6
interleukin 6
treatment
ISO
DNA:SNPs:promoter:rs1800795 (human)
RGD
PMID:27812403
RGD:14975294
NCBI chrNW_004955410:25,079,835...25,084,390
G
Isg15
ISG15 ubiquitin like modifier
treatment
ISO
RGD
PMID:28036111
RGD:40400915
NCBI chrNW_004955486:9,706,878...9,707,876
Ensembl chrNW_004955486:9,706,703...9,707,949
G
Itgb6
integrin subunit beta 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18221819
NCBI chrNW_004955449:13,387,013...13,520,879
Ensembl chrNW_004955449:13,448,084...13,520,879
G
Krt18
keratin 18
disease_progression severity
ISO
protein:increased expression:serum (human) protein:increased degradation:serum (human) protein:increased expression:liver, serum (human)
RGD
PMID:19333204 PMID:22404726 PMID:23820504 PMID:30839434
RGD:18337481 RGD:18337493 RGD:18337496 RGD:18337500
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
G
Krt8
keratin 8
ISO
protein:increased phosphorylation:liver (human)
RGD
PMID:15368451
RGD:14401583
NCBI chrNW_004955458:178,954...190,310
G
Lep
leptin
ISO
protein:altered localization:serum (human)
RGD
PMID:11336170
RGD:21201249
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
Lepr
leptin receptor
ISO
mRNA:altered expression:liver, peripheral blood mononuclear cell
RGD
PMID:17060687
RGD:21079470
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
G
Lgals3
galectin 3
ISO
mRNA:increased expression:CD19+Bcell:
RGD
PMID:20189883
RGD:32716380
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
G
LOC102011841
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
severity
ISO
DNA:polymorphism:promoter: 1260C>A (rs10877012) (human)
RGD
PMID:21145801
RGD:25671413
NCBI chrNW_004955458:5,472,404...5,477,001
Ensembl chrNW_004955458:5,472,404...5,477,001
G
LOC102025724
HLA class II histocompatibility antigen, DP alpha 1 chain
disease_progression
ISO
DNA:SNP, haplotype: :rs3077, rs9277534(human)
RGD
PMID:24897020
RGD:14694819
NCBI chrNW_004955437:1,644,037...1,657,094
Ensembl chrNW_004955437:1,643,238...1,651,071
G
LOC102026469
HLA class II histocompatibility antigen, DP beta 1 chain
ameliorates
ISO
mRNA:increased expression:peripheral blood mononuclear cell(human) DNA:polymorphism: :HLA-DPB1*04:01 (human)
RGD
PMID:27601657 PMID:28332201
RGD:150429796 RGD:150429805
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
G
Mbl2
mannose binding lectin 2
treatment
ISO
DNA:haplotype:promoter, exon: DNA:SNPs:promoter,exon:
RGD
PMID:18336595 PMID:25956563
RGD:11076743 RGD:14696820
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
G
Ncr3
natural cytotoxicity triggering receptor 3
disease_progression treatment
ISO
protein:decreased expression:peripheral blood mononuclear cell, natural killer cell (human) protein:increased expression:peripheral blood mononuclear cell, natural killer cell (human)
RGD
PMID:16322112 PMID:20550548 PMID:21168454 PMID:21695691 PMID:23813131
RGD:40400738 RGD:40818079 RGD:40818295 RGD:40818296 RGD:40818297
NCBI chrNW_004955437:130,360...134,751
G
Nfkb1
nuclear factor kappa B subunit 1
disease_progression
ISO
DNA:insertion:promoter: -94insATTG (rs28362491) (human)
RGD
PMID:26827631
RGD:11572306
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:19628656
RGD:6483809
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
associated with liver cirrhosis;mRNA, protein:decreased expression:liver (human) mRNA, protein:decreased expression:liver hepatocytes
RGD
PMID:15685545
RGD:5683635
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
G
Prdx5
peroxiredoxin 5
ISO
mRNA:decreased expression:liver, blood (human)
RGD
PMID:32103340
RGD:41404682
NCBI chrNW_004955422:20,763,822...20,766,976
Ensembl chrNW_004955422:20,761,495...20,766,976
G
Prf1
perforin 1
disease_progression
ISO
protein:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:25148254
RGD:40813739
NCBI chrNW_004955437:20,700,912...20,705,076
Ensembl chrNW_004955437:20,700,718...20,706,929
G
Slc11a1
solute carrier family 11 member 1
disease_progression
ISO
DNA:polymorphisms, haplotype:promoter (human)
RGD
PMID:14960532
RGD:5684961
NCBI chrNW_004955453:14,980,562...14,995,118
Ensembl chrNW_004955453:14,980,562...14,995,608
G
Slc6a4
solute carrier family 6 member 4
susceptibility
ISO
associated with alexithymia;DNA:haplotypes, multiple:
RGD
PMID:26609890
RGD:11352995
NCBI chrNW_004955481:3,088,440...3,122,421
Ensembl chrNW_004955481:3,088,416...3,125,711
G
Smad4
SMAD family member 4
ISO
protein:increased expression:liver:
RGD
PMID:29924446
RGD:21066342
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
G
Spp1
secreted phosphoprotein 1
treatment
ISO
DNA:SNPs:promoter:-443C>T, -1748G>A (human)
RGD
PMID:15868370
RGD:1581374
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
Stat3
signal transducer and activator of transcription 3
severity
ISO
RGD
PMID:17318196
RGD:8694293
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Tlr3
toll like receptor 3
treatment severity disease_progression susceptibility
ISO
treatment:peginterferon plus ribavirin. DNA:SNP:cds:p.Leu412Phe(human) DNA:SNP: :rs3775290(human) DNA:SNP: :rs13126816 (human)
RGD
PMID:19674283 PMID:23220997 PMID:23240626 PMID:28480979 PMID:29860675 PMID:30321082 More...
RGD:21079422 RGD:21079423 RGD:21079427 RGD:21079428 RGD:21079430 RGD:21079435
NCBI chrNW_004955403:22,977,882...23,001,392
Ensembl chrNW_004955403:22,979,120...23,001,467
G
Tlr4
toll like receptor 4
susceptibility
ISO
DNA:SNP: :rs2148356(human) protein:increased expression:serum:
RGD
PMID:26095186
RGD:14700655
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
Tlr9
toll like receptor 9
severity
ISO
mRNA, protein:decreased expression:peripheral blood mononuclear cell (human) protein:increased expression:liver, peripheral blood mononuclear cell (human)
RGD
PMID:19513613 PMID:23026026
RGD:18337470 RGD:18337477
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
G
Tnf
tumor necrosis factor
severity treatment
ISO
protein:increased expression:plasma (human) protein:increased expression:serum (human)
RGD
PMID:9047083 PMID:9440625 PMID:25708446
RGD:14995307 RGD:14995439 RGD:38456002
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
ISO
RGD
PMID:21152182
RGD:8661764
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
G
Usp18
ubiquitin specific peptidase 18
treatment
ISO
RGD
PMID:28036111
RGD:40400915
NCBI chrNW_004955454:6,171,575...6,200,879
Ensembl chrNW_004955454:6,171,569...6,203,091
G
Vdr
vitamin D receptor
no_association treatment
ISO
DNA:polymorphism: :
RGD
PMID:26725771 PMID:27263300
RGD:14401746 RGD:14401749
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:missense mutation:cds:p.R194W, p.R280H, p.R399Q (human)
RGD
PMID:29935355
RGD:15036797
NCBI chrNW_004955555:1,293,416...1,315,839
Ensembl chrNW_004955555:1,293,416...1,315,839
G
Zc3h12a
zinc finger CCCH-type containing 12A
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:21739451 PMID:25225661
RGD:39938960 RGD:39938976
NCBI chrNW_004955452:15,306,398...15,314,959
Ensembl chrNW_004955452:15,305,775...15,314,959
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all